United States· US:68163-748_3fef0ee0-c60c-a9de-e063-6394a90a99d6
DRx Choice Childrens Stuffy Nose and Chest Congestion
A medicinal product containing guaifenesin; phenylephrine hydrochloride, registered in United States by RARITAN PHARMACEUTICALS.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
- Manufacturer
- RARITAN PHARMACEUTICALS
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 6, 2026
Packs & prices · 2
- ndc1168163748041 BOTTLE in 1 CARTON (68163-748-04) / 118 mL in 1 BOTTLE
- ndc1168163-748-04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bfaa94da-1f45-47f4-97a5-ac1db8edfe0e GET /v1/drugs/bfaa94da-1f45-47f4-97a5-ac1db8edfe0e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100; 2.5",
"substance": "GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE",
"productndc": "68163-748",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/5mL; mg/5mL",
"application_number": "M012",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about guaifenesin; phenylephrine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.